id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-316743-q6gbxghx	Madhu, S. V.	Post COVID-19 diabetes care—lessons and challenges	2020-06-04		.txt	text/plain	1690	76	42	Some of the issues and challenges that have emerged include the reported high incidence [1, 2] of COVID-19 infections among patients with diabetes mellitus (DM), the greater severity, and higher rates of progression resulting in a higher number of ICU admissions [3] and higher mortality reported in them [1, 2] . As physicians involved in diabetes care, we need to advise our patients accordingly besides telling them to follow with greater intensity all the general measures to prevent exposure to COVID-19 infection. DPP4 inhibitors are another class of antidiabetic agents which are believed to have a potential to reduce the incidence and severity of complications associated with COVID-19 infections particularly in diabetic patients. Statins and ACE inhibitors are 2 groups of drugs very commonly prescribed to diabetic patients, and it is necessary to critically evaluate the current evidence regarding the benefit or risk associated with their continued use.	./cache/cord-316743-q6gbxghx.txt	./txt/cord-316743-q6gbxghx.txt